"SimcoDerm is a center for clinical trials on serious and chronic skin conditions like all skin cancers especially Melanoma, psoriasis, alopecia, acne, prurigo, atopic dermatitis and many other skin diseases."

During the past decade, SimcoDerm Medical and Surgical Dermatology Center conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 14 clinical trials were completed, i.e. on average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 14 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SimcoDerm Medical and Surgical Dermatology Center" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Concert Pharmaceuticals" with 3 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SimcoDerm Medical and Surgical Dermatology Center" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SimcoDerm Medical and Surgical Dermatology Center" are "Atopic Dermatitis" (6 trials), "Psoriasis" (4 trials), "Acne Vulgaris" (3 trials), "Alopecia Areata" (3 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "SimcoDerm Medical and Surgical Dermatology Center" in a lesser frequency.

Most popular intervention types in "SimcoDerm Medical and Surgical Dermatology Center" are "Drug" (25 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Vehicle" (3 trials), "Baricitinib" (2 trials), "CTP-543" (2 trials) and "Lebrikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "SimcoDerm Medical and Surgical Dermatology Center" are 27 trials for "All" genders.

Currently, there are NaN active trials in "SimcoDerm Medical and Surgical Dermatology Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 20 completed trials in SimcoDerm Medical and Surgical Dermatology Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in SimcoDerm Medical and Surgical Dermatology Center, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".